Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung CancerRomán Pérez-Soler, Philip Bonomi|Journal of Clinical Oncology|2004Cited by 1.1k
The Prognostic Value of Chromosome 7 Polysomy in Non-small Cell Lung Cancer Patients Treated with GefitinibLela Buckingham, Philip Bonomi, John S. Coon et al.|Journal of Thoracic Oncology|2007Cited by 40
Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.David S. Ettinger, Bruce W. Dana, Joseph C. Allegra et al.|PubMed|1986Cited by 39
PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapyMary J. Fidler, Philip Bonomi, Larry E. Morrison et al.|British Journal of Cancer|2011Cited by 20
Metastatic breast cancer: preliminary results with oral hormonal therapy.Joseph C. Allegra, Lawrence Einhorn, Joseph Bertino et al.|PubMed|1985Cited by 17